By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Clovis Oncology 

1871 Folsom Street

Boulder  Colorado  80302  U.S.A.
Phone: n/a Fax: n/a


Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado.


April 20, 2009


Founders: Patrick Mahaffy, and Erle Mast

CEO and Co-founder: Patrick Mahaffy

CMO (Medical): Lindsey Rolfe


Please click here for Clovis Oncology job opportunities.


Please click here for clinical trial information.


All Products

Key Statistics

Ownership: Public

Web Site: Clovis Oncology
Symbol: CLVS

Company News
A Biotech Binary Event Playbook: How To Play Clovis Oncology (CLVS) And Tesaro (TSRO) Ahead Of Label Decision 8/9/2017 8:45:38 AM
Clovis Oncology (CLVS) Announces Second Quarter 2017 Operating Results 8/3/2017 8:11:41 AM
Clovis Oncology (CLVS) Sell-Off May Be Overdone 8/1/2017 6:34:17 AM
Bristol-Myers Squibb (BMY), Clovis Oncology (CLVS) Ink Pact to Marry Their PD-1/PARP Drugs in Phase II and III 7/31/2017 7:00:47 AM
Clovis Oncology (CLVS) To Announce Second Quarter 2017 Financial Results And Host Webcast Conference Call On August 2 7/19/2017 7:29:35 AM
Will AbbVie (ABBV) Outsmart Biosimilars, And Can Clovis Oncology (CLVS) Win The PARP Race? 6/27/2017 6:55:48 AM
Clovis Oncology (CLVS) Announces Exercise In Full Of Underwriters’ Option To Purchase Additional Shares Of Common Stock 6/22/2017 6:51:19 AM
Clovis Oncology (CLVS) Announces Upsizing And Pricing Of Public Offering Of Common Stock 6/21/2017 6:43:35 AM
Clovis Oncology (CLVS) Announces Proposed Offering Of Common Stock 6/20/2017 7:07:14 AM
Clovis Oncology (CLVS) Stock Soars as Ovarian Cancer Trial Dazzles 6/19/2017 5:48:20 AM